Literature DB >> 7978005

Altered antroduodenal motility after cholecystectomy.

G Perdikis1, P Wilson, R Hinder, E Redmond, G Wetscher, P Neary, T Adrian, E Quigley.   

Abstract

BACKGROUND: Persistent nonspecific symptoms such as epigastric pain, bloating, nausea, and bilious vomiting are common following cholecystectomy. The etiology of these symptoms is unknown, but abnormal antroduodenal motility associated with duodenogastric reflux (DGR) is a possible cause. PATIENTS AND METHODS: Sixteen postcholecystectomy patients and 19 healthy volunteers ("normals") were studied. Ten of the patients were asymptomatic and 6 were symptomatic. The study consisted of a 4-hour 99mTc-DISIDA (diisopropyl imidodiacetic acid) infusion and gastric aspiration, 24-hour intragastric pH monitoring, and 24-hour ambulatory antroduodenal manometry.
RESULTS: The postcholecystectomy patients showed increased DGR of the infused 99mTc-DISIDA. The data are given as coulter counts x 10(6)/min. The increase was more marked in symptomatic postcholecystectomy patients (2.54 +/- 0.15) compared to asymptomatic patients (1.21 +/- 0.46) or normals (0.26 +/- 0.15). Postcholecystectomy patients had increased percentage of time with intragastric pH > 3. In the supine period in particular, the pH was > 3 in symptomatic patients 25.4% +/- 7.7% of the time versus 8.1% +/- 4.3% for asymptomatic patients (P < 0.01). The antral phase III frequency after cholecystectomy was 2.5 +/- 0.09 cycles/min compared to 3.2 +/- 0.08 cycles/min in normals (P < 0.0001). Furthermore, propagation of the phase III front in the duodenum was significantly slowed to 0.14 +/- 0.02 cm/s after cholecystectomy compared to 0.27 +/- 0.02 cm/s in normals (P < 0.001). The duration of phase III in the proximal duodenum after cholecystectomy was also decreased to 4.3 +/- 0.27 min compared to 5.9 +/- 0.35 min in normals (P < 0.005).
CONCLUSIONS: Fasting antroduodenal motility is altered after cholecystectomy. The abnormality is associated with increased DGR, which is more marked in symptomatic patients.

Entities:  

Mesh:

Year:  1994        PMID: 7978005     DOI: 10.1016/s0002-9610(05)80131-x

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  19 in total

1.  Cholecystectomy in patients with normal gallbladder function did not alter characteristics in duodenal motility which was not correlated to size of bile acid pool.

Authors:  P V Andersen; J Mortensen; E Oster-Jørgensen; L Rasmussen; S A Pedersen; N Qvist
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

2.  Duodenogastric reflux following biliary reconstruction after excision of choledochal cyst.

Authors:  K Takada; Y Hamada; K Watanabe; A Tanano; K Tokuhara; Y Kamiyama
Journal:  Pediatr Surg Int       Date:  2005-01       Impact factor: 1.827

3.  Changes of gastrointestinal myoelectric activity and bile acid pool size after cholecystectomy in guinea pigs.

Authors:  Xue-Mei Zhang; Lei Dong; Li-Na Liu; Bi-Xia Chang; Qian He; Qian Li
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

4.  Alkaline reflux gastritis: early and late results of surgery.

Authors:  Basile Zobolas; George H Sakorafas; Irene Kouroukli; Mikes Glynatsis; George Peros; John Bramis
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

5.  Rabeprazole combined with hydrotalcite is effective for patients with bile reflux gastritis after cholecystectomy.

Authors:  Huimin Chen; Xiaobo Li; Zhizheng Ge; Yunjie Gao; Xiaoyu Chen; Yun Cui
Journal:  Can J Gastroenterol       Date:  2010-03       Impact factor: 3.522

6.  Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease.

Authors:  G J Wetscher; M Gadenstaetter; P J Klingler; H Weiss; P Obrist; H Wykypiel; A Klaus; C Profanter
Journal:  Ann Surg       Date:  2001-11       Impact factor: 12.969

7.  Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux.

Authors:  G J Wetscher; R A Hinder; T Smyrk; G Perdikis; T E Adrian; C Profanter
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

8.  Primary duodenogastric reflux in children and adolescents.

Authors:  Dominique Hermans; Etienne-Marc Sokal; Jean-Marie Collard; Renato Romagnoli; Jean-Paul Buts
Journal:  Eur J Pediatr       Date:  2003-06-26       Impact factor: 3.183

9.  Gallstones increase the prevalence of Barrett's esophagus.

Authors:  Juntaro Matsuzaki; Hidekazu Suzuki; Keiko Asakura; Yoshimasa Saito; Kenro Hirata; Toru Takebayashi; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2009-11-12       Impact factor: 7.527

10.  Selection of patients with gastroesophageal reflux disease for antireflux surgery based on esophageal manometry.

Authors:  Alexander Klaus; Michael Gadenstaetter; Gilbert Mühlmann; Werner Kirchmayr; Christoph Profanter; Sami R Achem; Gerold J Wetscher
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.